Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Phiome is a biotechnology company dedicated to mapping and harnessing the human virome—the vast collection of viruses inhabiting the human body. Founded by pioneers in microbiome research from the Weizmann Institute of Science, the company utilizes a proprietary computational platform to analyze the complex interactions between the virome and human health. Phiome aims to identify viral signatures and bacteriophages associated with diseases such as inflammatory bowel disease, metabolic disorders, and oncology. By translating virome data into precision medicine solutions, the company seeks to develop novel therapeutics and diagnostics that address unmet medical needs. Phiome's approach represents a significant advancement in microbiome science, moving beyond bacterial analysis to explore the therapeutic potential of the body's viral ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Phiome.